“Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s17. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1170.